Luye Pharma Group Ltd.

This study is testing a new, once-daily extended-release pill called LY03020 for adults experiencing an acute worsening of schizophrenia symptoms. It aims to see if the pill is better than a placebo at reducing overall psychosis symptoms, as measured by a standard rating scale. T…

This study is testing a new oral drug, LPM6690176, to see if it is safe and effective when added to standard chemotherapy for people with advanced colorectal cancer that has spread and has a specific genetic change (RAS mutation). The first part of the study will find the safest …